Toggle Offcanvas
...
 
Erythropoietin Tenders

Erythropoietin Tenders

View Erythropoietin tenders, RFPs and contracts. Bid on readily available Erythropoietin tenders with the best and most comprehensive tendering platform, since 2002.
Erythropoietin is a natural hormone that regulates red blood cell production in the bone marrow. It is used medically to treat anemia, especially in patients with kidney disease or undergoing chemotherapy.

Bidding for Erythropoietin tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Erythropoietin.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Erythropoietin market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Erythropoietin tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

74 Live Notices for Erythropoietin Tenders

Showing 1 to 20

Np40725 Erythropoietin Stimulating Agents
country United Kingdom
posting date31 Jul 2025
deadline01 Sep 2025
Erythropoietin Medicine For Medical Examination, Medical Treatment And Outpatient At Ha Tinh General Hospital In 2025
country Vietnam
posting date28 Jul 2025
deadline01 Aug 2025
Open House Pharmaceutical Dact Treaties Erythropoietin Alfa, Atc B03Xa01
country Germany
posting date14 Jul 2025
deadline03 Jul 2027
Open House Pharmaceutical Dact Treaties Erythropoietin Alfa, Atc B03Xa01
country Germany
posting date13 Jul 2025
deadline03 Jul 2027
Open House Pharmaceutical Department Treaties Erythropoietin Zeta, Atc B03Ax01
country Germany
posting date16 Jun 2025
deadline03 Jun 2027
Open House Pharmaceutical Department Treaties Erythropoietin Zeta, Atc B03Ax01
country Germany
posting date16 Jun 2025
deadline03 Jun 2027
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028

Share Share this page